ETH Zurich implant converts glucose to urine without insulin
Researchers at ETH Zurich developed an electronic implant that lowers blood sugar and promotes weight loss in diabetic mice on November 2, 2026.
Device mechanism explained
The new technology employs a special electrically powered catalyst to process excess glucose. This catalyst transforms the sugar into a substance that leaves the body through urine. The system operates without requiring insulin injections or traditional medication.
Results in animal tests
Early trials involving diabetic mice showed the implant successfully regulated blood sugar levels. These animals also experienced weight loss while the device functioned. The process prevents unwanted energy from being stored as fat within the body.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.